Novartis has jettisoned an anti-cancer protein from its pipeline after the molecule failed to shrink tumors in 30 patients with advanced disease. The pharma giant halted the phase 1 trial of QEQ278 ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...

TOLEDO, Ohio (WTVG) - The City of Toledo is seeking input from residents on the future of the Chester J. Zablocki Community Center. The goal of the Reimagine Zablocki initiative to gather ideas and ...